Biotechnology
News Category
Instinct Bio Partners With INVITRX to Bring GENREVER to U.S. and Boost Indonesia Regenerative Medicine
Instinct Bio announced a strategic collaboration with INVITRX to license its GENREVER cosmetic brand for U.S. manufacture and sale, and to supply exos...
BRAIN Biotech AG Appoints Dr. Sven K. Weber as New CEO, Succeeding Adriaan Moelker
Dr. Sven K. Weber will become CEO of BRAIN Biotech AG on October 1, 2026, bringing extensive experience from BASF's global enzyme business to drive gr...
VERAXA Biotech Expands Patent Portfolio to Bolster Next-Generation Cancer Therapies
VERAXA Biotech's expanded patent portfolio, including new filings for BiTAC-TCE and BiTAC-ADC platforms, strengthens its position in developing safer,...
MindBio Therapeutics Delivers Edge AI Kiosk Prototypes for Rapid Impairment Screening in Safety-Sensitive Industries
MindBio Therapeutics has completed its first Edge AI kiosk prototypes for voice-based impairment detection, targeting workplace safety in mining, avia...
VERAXA Biotech Appoints Dr. Christoph Erkel as Chief Scientific Officer to Drive BiTAC(R) Cancer Therapy Platform Toward Clinical Development
VERAXA Biotech (NASDAQ: VRXA) names antibody therapeutics expert Dr. Christoph Erkel as CSO to advance its proprietary BiTAC(R) platform and prepare l...
VERAXA Biotech Expands Patent Portfolio to Protect Next-Generation Cancer Therapy Platforms Through 2047
VERAXA Biotech AG announced the expansion of its intellectual property portfolio with new patent filings for its BiTAC-TCE and BiTAC-ADC platforms, ex...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology
Greenland Mines (GRML) received a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP portfolio and...
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial While Commercial Product unbuzzd Generates Revenue
Quantum BioPharma's executive outlines the company's dual strategy of advancing its lead MS drug candidate Lucid-MS into human trials and commercializ...
VERAXA Biotech Shareholders Overwhelmingly Approve Corporate Governance and Financing Measures
VERAXA Biotech shareholders approved proposals to enhance corporate governance and financing flexibility, supporting the company's long-term growth st...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology Targeting Neurodegenerative Diseases
Greenland Mines Ltd. has been granted a Canadian patent for its Klotho-based gene therapy technology, covering 42 claims for treating neurodegenerativ...
NanoViricides Awaits Regulatory Decision on Ebola Trial for NV-387 Oral Gummies
NanoViricides has submitted an application to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approve...
Lantern Pharma Receives EMA Clearance for LP-184 Bladder Cancer Trial in Europe
Lantern Pharma announced EMA clearance for a Phase 1b/2 trial of LP-184 in advanced bladder cancer, advancing its AI-driven precision oncology strateg...
GeoVax Reports Q2 2026 Financial Results and Advances GEO-MVA Toward Pivotal Study
GeoVax Labs reported a narrower net loss for Q2 2026 and provided updates on its lead programs, including preparations for a pivotal immunobridging st...
VERAXA Biotech Advances Bispecific ADC Program Under OmniAb Collaboration
VERAXA Biotech advances its bispecific ADC program VXA-222 after OmniAb completes discovery work, moving toward next-phase development for precision s...
Quantum BioPharma Outlines Lucid-MS Development Strategy and Commercial Growth Plans in BioMedWire Podcast
Quantum BioPharma's executive details the advancement of its lead multiple sclerosis drug candidate Lucid-MS toward Phase 2 trials and the commercial ...
Onco-Innovations Advances Lead Oncology Candidate ONC010 Toward Clinical Studies
Onco-Innovations Limited is progressing its lead PNKP inhibitor ONC010 through manufacturing scale-up, partnerships, and regulatory planning to enable...
Tonix Pharmaceuticals Schedules Second-Quarter 2026 Financial Results Call
Tonix Pharmaceuticals announced it will report Q2 2026 financial results and operational highlights on August 10, 2026, with a conference call providi...
VERAXA Biotech Advances Bispecific ADC Program VXA-222 Under OmniAb Collaboration
VERAXA Biotech (NASDAQ: VRXA) announced a key technical milestone in its collaboration with OmniAb (NASDAQ: OABI), allowing its bispecific ADC program...
Onco-Innovations Combines PNKP Inhibition, Nanoparticle Delivery, and AI to Address Key Challenges in Cancer Drug Development
Onco-Innovations is integrating a novel DNA repair target, nanoparticle drug delivery, and artificial intelligence to overcome resistance, trial failu...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Lead BiTAC Platform Development
VERAXA Biotech appointed Christoph Erkel as CSO to advance its BiTAC platform for solid tumor therapies, signaling a strategic push toward clinical de...
VERAXA Biotech Gains Regulatory Support for BiTAC®-TCE Development from Germany's Paul-Ehrlich-Institute
VERAXA Biotech received positive scientific advice from Germany's Paul-Ehrlich-Institute, reducing uncertainty for its lead BiTAC®-TCE program as it a...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations Ltd. is advancing its lead asset ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Treatment Methods
Lantern Pharma (NASDAQ: LTRN) announced a U.S. patent allowance for methods selecting patients for LP-184 therapy using a three-gene biomarker signatu...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform for Solid Tumor Therapies
VERAXA Biotech has appointed Christoph Erkel, Ph.D., as Chief Scientific Officer to lead the development of its proprietary BiTAC platform technologie...
BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch
BioAdaptives has completed commercial manufacturing and logistics supply chain readiness to launch its MyndSystem and Xcellara wellness platforms next...
iOrganBio Appoints Lee L. Rubin, Ph.D. to Scientific Advisory Board
iOrganBio strengthens its Scientific Advisory Board with the appointment of Dr. Lee L. Rubin, a leading expert in stem cell biology and translational ...
Creative Biolabs Expands Microfluidics Solutions to Accelerate High-Throughput Antibody Discovery
Creative Biolabs has expanded its integrated microfluidics portfolio to accelerate high-throughput antibody discovery by combining droplet generation ...
Quantum BioPharma Targets Two Major Neurological Conditions with Novel Pipeline
Quantum BioPharma is developing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, addressing significant unmet needs in brain diso...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Everolimus Formulation Sapu003
The publication of preclinical data for Sapu003, an intravenous formulation of everolimus, supports its ongoing Phase 1 clinical trial and validates O...
Kairos Pharma Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has partnered with Bayer to test its antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate cancer, ai...
VERAXA Biotech Receives Positive Regulatory Feedback from German PEI for BiTAC-TCE Program
VERAXA Biotech has obtained Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC-TCE candida...
VivoSim Labs Secures $4 Million Private Placement with Healthcare-Focused Investor
VivoSim Labs raises $4 million through a private placement to fund working capital and general corporate purposes, highlighting continued investor int...
Greenwich LifeSciences Provides Update on Phase 3 FLAMINGO-01 Trial, Including Expanded Enrollment and Positive DSMB Recommendation
Greenwich LifeSciences announced that its Phase 3 trial for GLSI-100, an immunotherapy to prevent breast cancer recurrence, received a positive recomm...
Quantum BioPharma Develops Two-Pronged Attack on Brain Disorders Affecting Millions
Quantum BioPharma Ltd. is advancing a pipeline targeting multiple sclerosis and alcohol intoxication with novel therapies, addressing significant unme...
American Fusion Inc. Secures Texas Certificate of Registration for Fusion Engine Testing
American Fusion Inc. received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, enabling testing of its Texatron Fusion Engi...
Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer
A World Health Organization-commissioned review of 13 studies found no evidence that mobile phone use causes brain cancer, shifting focus to treatment...
Quantum BioPharma Hits Key Study Milestone with Promising Early MS Imaging Data
Quantum BioPharma announced that its imaging study for multiple sclerosis has reached halfway enrollment with encouraging preliminary results, potenti...
GeoVax Highlights Alignment of GEO-MVA with HHS/ASPR's Five-Year Preparedness Strategy
GeoVax Labs announces that its GEO-MVA vaccine platform aligns with the HHS/ASPR's five-year medical countermeasure strategy emphasizing domestic manu...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, clarifying the development path and suppor...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech AG received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on development strate...
Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials received a Japan patent allowance for its proprietary GelrinC manufacturing process, strengthening its IP portfolio and position...
MindBio Therapeutics Develops Voice-Based AI Platform for Real-Time Impairment Detection
MindBio Therapeutics is advancing an AI-powered voice analysis platform to detect drug and alcohol impairment in real time, addressing safety and scal...
Gut Microbial Metabolites Linked to Improved Cancer Immunotherapy Response
A study reveals that metabolites from certain gut bacteria can enhance the effectiveness of cancer immunotherapy, offering potential for new treatment...
SS Innovations Appoints Veteran Medtech Finance Executive Sarah M. Romano as CFO Amid Global Expansion
SS Innovations International Inc. has appointed Sarah M. Romano as CFO, signaling a strategic move to strengthen financial leadership as it pursues FD...
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics
Creative Biolabs announces an integrated platform combining microfluidics and electrochemical biosensors to enable rapid, scalable development of poin...
BioAdaptives Details Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives outlines its cellular wellness platform, backed by a clinical trial showing a 268.8% increase in stem cells, as it prepares to launch the...
NeuroOne Expands Drug Delivery Platform Through Collaboration with Mayo Clinic on Pediatric Brain Cancer Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic to evaluate a novel treatment for pediatric diffuse midline glioma using its ...
Oncotelic Therapeutics Launches AI-Powered Manufacturing Platform to Aid Biotech Development
Oncotelic Therapeutics has introduced an AI-driven manufacturing services platform combining its PDAOAI architecture with robotics from TechForce Robo...